Rat Anti-Mouse CD86
- Known as:
- Rat Antibody toMouse CD86
- Catalog number:
- 128-10054-1
- Product Quantity:
- 500
- Category:
- -
- Supplier:
- Ray Biotech
- Gene target:
- Rat Anti-Mouse CD86
Related genes to: Rat Anti-Mouse CD86
- Gene:
- CD86 NIH gene
- Name:
- CD86 molecule
- Previous symbol:
- CD28LG2
- Synonyms:
- B7.2, B7-2
- Chromosome:
- 3q13.33
- Locus Type:
- gene with protein product
- Date approved:
- 1994-12-07
- Date modifiied:
- 2016-10-05
Related products to: Rat Anti-Mouse CD86
Related articles to: Rat Anti-Mouse CD86
- Immune and malignant epithelial cells shape each other through ligand-receptor signaling in ovarian cancer. SPP1 interacts with CD44 and several integrins, but its cellular organization and clinical relevance remain unclear. - Source: PubMed
Publication date: 2026/09/22
Liu XiangyuXia LiSheng JindongCao XuchenWang Ke - Atherosclerosis (AS) is a major contributor to deaths from cardiovascular diseases. Yiqihuoxue Formula (YQHXF) reflects the traditional Chinese medicine principle of "Qi-invigorating and blood-activating." This study investigates the anti-atherosclerotic effects and mechanism of YQHXF through the signal transducer and activator of transcription 6 (STAT6)/ peroxisome proliferator-activated receptor gamma (PPARĪ³) signaling pathway and macrophage polarization. - Source: PubMed
Publication date: 2026/09/22
Xie QuanWang BindingZhuang JinliGuan YiYang XiaohongLi JianfengCun ShengyuChen YantingQin YaLi Yanqing - Persistent inflammation and impaired macrophage efferocytosis contribute to liver injury during bacterial liver abscesses (BLA). This study was conducted to investigate whether METTL3 alleviates BLA by promoting macrophage efferocytosis through m6A methylation of Nrf2 mRNA. - Source: PubMed
Wang GenwangLuo DingPang YuGao ChanjuanJin DongWang Qi - Metabolic dysfunction-associated steatotic liver disease (MASLD) is characterized by dysregulated hepatic lipid metabolism and persistent inflammatory remodeling. Apigenin has lipid-regulatory and anti-inflammatory activities, but the molecular basis linking these effects remains incompletely understood. This study investigated whether SMAD4-associated signaling contributes to the coordinated regulation of hepatocyte lipogenesis and macrophage inflammatory activation by apigenin. C57BL/6J mice were fed a high-fat diet (HFD) to establish MASLD and treated with apigenin. Palmitic acid (PA)-treated HepG2 cells and lipopolysaccharide (LPS)-stimulated RAW264.7 macrophages were used as complementary in vitro models. Hepatic lipid accumulation, inflammatory responses, macrophage phenotype, and SMAD4-associated signaling were evaluated using biochemical assays, histological staining, ELISA, RT-qPCR, Western blotting, immunohistochemistry, and immunofluorescence. Molecular docking was used to predict the potential interaction between apigenin and SMAD4, a cellular thermal shift assay (CETSA) was performed in HepG2 cells to assess cellular target engagement of SMAD4 by apigenin, and SMAD4/Smad4 overexpression was used to evaluate functional involvement. Apigenin alleviated HFD-induced liver injury, dyslipidemia, and hepatic lipid deposition and suppressed the SREBP-1c/FAS/ACC lipogenic program in mouse liver and PA-treated HepG2 cells. Apigenin also reduced hepatic CD68-positive macrophage accumulation, decreased CD86 and iNOS expression and pro-inflammatory cytokine levels, and attenuated M1-like inflammatory activation in vivo and in LPS-stimulated RAW264.7 macrophages. Molecular docking predicted a favorable interaction between apigenin and SMAD4, while CETSA demonstrated increased thermal stability of SMAD4 following apigenin exposure in HepG2 cells, supporting cellular target engagement in this cellular context. Apigenin further attenuated SMAD4-associated signaling, whereas SMAD4/Smad4 overexpression partially counteracted its anti-lipogenic and anti-inflammatory effects in HepG2 cells and RAW264.7 macrophages, respectively. These findings indicate that apigenin alleviates HFD-induced MASLD by coordinately suppressing hepatocellular lipogenesis and macrophage-associated inflammatory activation and suggest that SMAD4-associated signaling contributes to these metabolic and inflammatory effects. - Source: PubMed
Publication date: 2026/10/05
Cao LijunZhao YongnaLi Ping - This study aims to explore the molecular mechanism of NOP2 in inducing neutrophil extracellular traps (NETs) and M1 macrophage polarization in a murine model of COPD. - Source: PubMed
Publication date: 2026/10/05
Guo ChunyanChen SaiShao ZhuxiangZhai Shengping